Salvage Therapy for Hodgkin’s Lymphoma: A Review of Current Regimens and Outcomes

Relapse/refractory Hodgkin lymphoma patients are still a clinical concern. Indeed, despite more effective first-line chemotherapy regimens and better stratification of unresponsive patients by clinical factors and use of early PET, roughly one-third of such patients need salvage chemotherapy and con...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagna, Luca, Santoro, Armando, Carlo-Stella, Carmelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603406/
https://www.ncbi.nlm.nih.gov/pubmed/33149713
http://dx.doi.org/10.2147/JBM.S250581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603406/
https://www.ncbi.nlm.nih.gov/pubmed/33149713
http://dx.doi.org/10.2147/JBM.S250581

Ejemplares similares